A Conversation with Dr. Andrew Badley, M.D., head of Mayo Clinic’s COVID-19 Research Task Force
Dr. Andrew Badley, MD, FRCP(C), FACP, FIDSA Professor and Chair, Dept of Molecular Medicine, Professor of Infectious Diseases, Chair - COVID-19 Research Task Force, Mayo Clinic, Rochester, MN Professor and Chair, Dept of Molecular Medicine, Professor of Infectious Diseases, Chair - COVID-19 Research Task Force, Mayo Clinic, Rochester, MN
Dr. Badley’s research focuses on virus-host interactions, particularly how viral proteins modify the host immune response and/or cell survival. This research informs novel strategies to treat virus infections including HIV and SARS-CoV2. In recognition of his work, Dr. Badley has received many awards and honors, including awards from Burroughs Wellcome Fund; the Dalhousie Alumnus Award, and the Outstanding Investigator Award, conferred by Mayo Clinic, and induction into the American Society of Clinical Investigation. Dr. Badley earned his B.S. and M.D. at Dalhousie University in Halifax, Nova Scotia. He subsequently completed an internal medicine residency and an infectious disease fellowship at Mayo Clinic School of Graduate Medical Education. He is recognized with the distinction of the HH Sheikh Khalifa Bin-Zayed Al-Nahyan Professorship in Infectious Diseases honoring Walter R. Wilson, M.D. He Chairs the Department of Molecular Medicine, and is the past Chair of Research in the Department of Medicine at Mayo Clinic. He has held numerous leadership positions within the Mayo Clinic, including being the Associate Dean of Research, and is the founder and past Director of the Office of Translation to Practice. Most recently Dr Badley has been appointed as Chair of the Mayo Clinic task force on SARS- CoV2 / COVID-19 research where he oversees all research activities including clinical trials related to the virus and the disease.